0001179110-16-028541.txt : 20160810
0001179110-16-028541.hdr.sgml : 20160810
20160810202147
ACCESSION NUMBER: 0001179110-16-028541
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160726
FILED AS OF DATE: 20160810
DATE AS OF CHANGE: 20160810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Onconova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001130598
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 267-759-3681
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20090526
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC
DATE OF NAME CHANGE: 20001226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reddy E Premkumar
CENTRAL INDEX KEY: 0001580071
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36020
FILM NUMBER: 161822738
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
4
1
edgar.xml
FORM 4 -
X0306
4
2016-07-26
0
0001130598
Onconova Therapeutics, Inc.
ONTX
0001580071
Reddy E Premkumar
C/O ONCONOVA THERAPEUTICS, INC.
375 PHEASANT RUN
NEWTOWN
PA
18940
1
0
0
0
Common Stock
2016-07-29
4
X
0
133000
4.10
A
266784
D
Subscription Rights (right to receive)
4.10
2016-07-26
4
X
0
133000
0
D
2016-07-08
2016-07-26
See footnote
133000
0
D
Warants (right to buy)
4.92
2016-07-29
4
X
0
99750
A
2016-07-29
2021-07-27
Common Stock
99750
99750
D
The common stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by the Issuer to all holders of the Issuer's common stock. Each holder received 1.5 subscription rights per share of stock owned, and each right allowed the recipient to purchase one unit, consisting of one share of common stock and 0.75 of a warrant to purchase one share of common stock. The subscription price per unit was $4.10. Holders of the subscription rights, including the Reporting Person, also had an overallotment privilege to subscribe for additional units not purchased by other holders, subject to allocation. The allocation of the overallotment privilege to persons who hold their securities through a broker was completed on August 1, 2016.
Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $4.92 from the date of issuance through July 27, 2021.
/s/ Ramesh Kumar as attorney-in-fact
2016-08-10